Published in Am J Trop Med Hyg on September 01, 2010
HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study. AIDS Res Ther (2012) 0.86
Neurology and the Global HIV Epidemic. Semin Neurol (2014) 0.81
Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya. J Neurol Sci (2011) 0.79
Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle Nerve (2013) 0.78
Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Clin Infect Dis (2011) 0.78
Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda. BMC Public Health (2014) 0.77
The reliability of the modified lower extremity functional scale among adults living with HIV on antiretroviral therapy, in Rwanda, Africa. SAHARA J (2014) 0.77
Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs. Pan Afr Med J (2016) 0.75
Genetics of HIV-associated sensory neuropathy and related pain in Africans. J Neurovirol (2017) 0.75
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health (2008) 5.32
Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr (2005) 4.19
The evolving concept of the healthy worker survivor effect. Epidemiology (1994) 3.88
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther (2007) 3.27
Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health (2005) 2.68
Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya. J Acquir Immune Defic Syndr (2007) 2.61
HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology (2006) 2.06
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr (2007) 1.97
HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve (2010) 1.51
Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology (2005) 1.39
Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology (2009) 1.35
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS (2008) 1.32
Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc (2006) 1.19
Diagnosis and management of HIV-associated neuropathy. Neurol Clin (2008) 1.09
[Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso]. Bull Soc Pathol Exot (2008) 0.87
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res Hum Retroviruses (2002) 2.89
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods (2004) 2.50
Evidence of dysregulation of dendritic cells in primary HIV infection. Blood (2010) 2.39
Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol (2004) 2.15
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS (2003) 1.99
A case-control study of gynecomastia in HIV-1-infected patients receiving HAART. AIDS Read (2004) 1.63
Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. J Infect Dis (2007) 1.59
Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis (2010) 1.52
Implementation of HIV testing at 2 New York City bathhouses: from pilot to clinical service. Clin Infect Dis (2009) 1.46
Practice policies for older anesthesiologists in academic departments: a national survey of academic departmental chairpersons. J Clin Anesth (2012) 1.39
Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J Infect Dis (2003) 1.35
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. J Infect Dis (2008) 1.22
Multidrug-resistant Salmonella Typhimurium in four animal facilities. Emerg Infect Dis (2005) 1.19
Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings. J Clin Microbiol (2005) 1.14
Mycobacterium leprae inhibits dendritic cell activation and maturation. J Immunol (2007) 1.12
An Outbreak of Vibrio cholerae O1 infections on Ebeye Island, Republic of the Marshall Islands, associated with use of an adequately chlorinated water source. Clin Infect Dis (2003) 1.08
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults. Antivir Ther (2003) 1.02
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. J Infect Dis (2006) 1.01
Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay. PLoS One (2009) 0.93
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248). J Acquir Immune Defic Syndr (2004) 0.93
The Development and Implementation of an Outreach Program to Identify Acute and Recent HIV Infections in New York City. Open AIDS J (2010) 0.92
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. AIDS Res Hum Retroviruses (2004) 0.88
Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy. BMC Infect Dis (2012) 0.87
A reverse transcriptase assay for early diagnosis of infant HIV infection in resource-limited settings. J Trop Pediatr (2007) 0.84
FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children. J Acquir Immune Defic Syndr (2016) 0.83
The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya. AIDS Care (2013) 0.83
Multidrug-resistant Acinetobacter baumannii in New York City - 10 years into the epidemic. Infect Control Hosp Epidemiol (2009) 0.81
Bacterial diarrhea in HIV-infected patients: why Clostridium difficile, and why now? Clin Infect Dis (2005) 0.79
A randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy: recruitment, refusal, randomisation and missing data. BMC Res Notes (2014) 0.79
Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Clin Infect Dis (2011) 0.78
An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women. AIDS Res Hum Retroviruses (2014) 0.77
Measurement of antiretroviral drugs in the lungs of HIV-infected patients. HIV Ther (2010) 0.76
Early detection of HIV infection among Kenyan infants using a reverse transcriptase activity assay. Pediatr Infect Dis J (2012) 0.75
Risk factors for tuberculin skin test conversion among HIV-infected patients in New York City. Int J Infect Dis (2012) 0.75
Integrating Household Water Treatment, Hand Washing, and Insecticide-Treated Bed Nets into Pediatric HIV Care in Mombasa, Kenya: Impact on Diarrhea and Malaria Risk. J Acquir Immune Defic Syndr (2017) 0.75